1 – 29 of 29
- show: 250
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Rationale and design of INFINITY-SWEDEHEART : A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stent
(
- Contribution to journal › Article
- 2023
-
Mark
A cross-stakeholder approach to improving out-of-hospital cardiac arrest survival
(
- Contribution to journal › Article
-
Mark
Rationale and design of the DAPA-MI trial : Dapagliflozin in patients without diabetes mellitus with acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
The remote exercise SWEDEHEART study–Rationale and design of a multicenter registry-based cluster randomized crossover clinical trial (RRCT)
(
- Contribution to journal › Article
-
Mark
Rationale and design of BROKEN-SWEDEHEART : a registry-based, randomized, parallel, open-label multicenter trial to test pharmacological treatments for broken heart (takotsubo) syndrome
(
- Contribution to journal › Article
-
Mark
Clinical impact of influenza vaccination after ST- and non-ST-segment elevation myocardial infarction - insights from the IAMI trial
(
- Contribution to journal › Article
-
Mark
Routine revascularization with percutaneous coronary intervention in patients with coronary artery disease undergoing transcatheter aortic valve implantation – the third nordic aortic valve intervention trial – NOTION-3
(
- Contribution to journal › Article
-
Mark
Dual or single antiplatelet therapy after coronary surgery for acute coronary syndrome (TACSI trial) : Rationale and design of an investigator-initiated, prospective, multinational, registry-based randomized clinical trial
(
- Contribution to journal › Article
- 2022
-
Mark
Rationale and design of switch Swedeheart : A registry-based, stepped-wedge, cluster-randomized, open-label multicenter trial to compare prasugrel and ticagrelor for treatment of patients with acute coronary syndrome
(
- Contribution to journal › Article
- 2021
-
Mark
Long-term prognostic outcomes and implication of oral anticoagulants in patients with new-onset atrial fibrillation following st-segment elevation myocardial infarction
(
- Contribution to journal › Article
-
Mark
Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes : A prospective study
(
- Contribution to journal › Article
-
Mark
Helicobacter pylori screening in clinical routine during hospitalization for acute myocardial infarction
(
- Contribution to journal › Article
-
Mark
Randomized evaluation of beta blocker and ACE-inhibitor/angiotensin receptor blocker treatment in patients with myocardial infarction with non-obstructive coronary arteries (MINOCA-BAT) : Rationale and design: MINOCA-BAT: Rationale and design
(
- Contribution to journal › Article
-
Mark
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction : Sex-related outcomes from DETO2X-AMI
(
- Contribution to journal › Article
- 2020
-
Mark
No-touch saphenous vein grafts in coronary artery surgery (SWEDEGRAFT) : Rationale and design of a multicenter, prospective, registry-based randomized clinical trial
(
- Contribution to journal › Article
-
Mark
Accelerated treatment of endocarditis—The POET II trial : Rationale and design of a randomized controlled trial: Design and rationale of the POET II trial
(
- Contribution to journal › Article
-
Mark
Smartphone 12-lead ECG—Exciting but must be handled with care
(
- Contribution to journal › Letter
- 2019
-
Mark
Targeted hypothermia versus targeted Normothermia after out-of-hospital cardiac arrest (TTM2) : A randomized clinical trial—Rationale and design
(
- Contribution to journal › Article
-
Mark
Registry data on implantation of ICD is not necessarily reflective of an arrhythmic event
(
- Contribution to journal › Letter
- 2018
-
Mark
Design of DISCO—Direct or Subacute Coronary Angiography in Out-of-Hospital Cardiac Arrest study
(
- Contribution to journal › Article
-
Mark
Comparison between patients included in randomized controlled trials of ischemic heart disease and real-world data. A nationwide study
(
- Contribution to journal › Article
-
Mark
Caffeine and incidence of dyspnea in patients treated with ticagrelor
(
- Contribution to journal › Letter
-
Mark
Bivalirudin versus heparin with primary percutaneous coronary intervention
(
- Contribution to journal › Article
- 2017
-
Mark
Design and rationale for the Influenza vaccination After Myocardial Infarction (IAMI) trial. A registry-based randomized clinical trial
(
- Contribution to journal › Article
- 2016
-
Mark
Incidence and risk factors for thromboembolism and major bleeding in patients with mechanical valve prosthesis : A nationwide population-based study
(
- Contribution to journal › Article
-
Mark
Hypertension in adults with repaired coarctation of the aorta
(
- Contribution to journal › Article
-
Mark
Bivalirudin versus heparin in non-ST and ST-segment elevation myocardial infarction - A registry-based randomized clinical trial in the SWEDEHEART registry (the VALIDATE-SWEDEHEART trial)
(
- Contribution to journal › Article
-
Mark
Low real-world early stent thrombosis rates in ST-elevation myocardial infarction patients and the use of bivalirudin, heparin alone or glycoprotein IIb/IIIa inhibitor treatment : A nationwide Swedish registry report
(
- Contribution to journal › Article
- 2014
-
Mark
Circulating fibrosis biomarkers and risk of atrial fibrillation : The Cardiovascular Health Study (CHS)
(
- Contribution to journal › Article